Compounds having Formula I
##STR1##
are useful for partially or fully antagonizing, repressing, agonizing, or modulating
the glucocorticoid receptor and treating immune, autoimmune and inflammatory diseases
in a mammal. Also disclosed are pharmaceutical compositions comprising compounds
of Formula I and methods of inhibiting immune or autoimmune diseases in a mammal.